Spatial Transcriptomics of Meningeal Inflammation Reveals Variable Penetrance of Inflammatory Gene Signatures into Adjacent Brain Parenchyma

Sachin P. Gadani, Saumitra Singh, Sol Kim, Matthew D. Smith, Peter A. Calabresi, Pavan Bhargava

TL;DR

This study uses cutting-edge spatial transcriptomics to map the molecular landscape of meningeal inflammation in a mouse model of multiple sclerosis (MS). It reveals that inflammatory signals originating from the meninges don't uniformly spread into the brain parenchyma, but rather a specific subset of immune pathways "penetrate" to influence adjacent brain tissue, offering new insights into the mechanisms of grey matter damage in MS.

What Problem Does This Paper Address?

Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system. While current treatments are effective for relapsing forms, they struggle with progressive MS. A key factor in progressive MS is inflammation in the meninges (the membranes surrounding the brain), which is linked to grey matter pathology, leading to debilitating symptoms like cognitive impairment and depression. However, the precise molecular mechanisms by which meningeal inflammation causes this grey matter damage remain unclear. This paper aims to bridge this gap by precisely mapping the gene expression changes in both the inflamed meninges and the adjacent brain tissue to understand how inflammatory signals spread and impact the brain.

Methods

The researchers employed a multi-pronged approach:

  • Mouse Model: They used a mouse model of experimental autoimmune encephalomyelitis (EAE) induced by myelin oligodendrocyte glycoprotein (MOG) peptide, which mimics aspects of MS, including meningeal inflammation.
  • MRI Guidance: Magnetic Resonance Imaging (MRI) was used to non-invasively identify and track areas of meningeal inflammation in the living mice over time. This allowed for precise targeting of these regions for subsequent analysis.
  • Spatial Transcriptomics (10x Genomics Visium): This is the core technology. It allows for the simultaneous measurement of gene expression across thousands of individual spots on a tissue section, preserving the spatial context. This is crucial for understanding how gene activity varies across different anatomical regions.
  • Data Processing & Analysis: Standard bioinformatics pipelines were used for quality control, normalization, dimensionality reduction (UMAP, PCA), and differential gene expression analysis (DESeq2). Novel approaches included:
  • Unbiased Clustering: Identifying distinct cell populations or functional states based on gene expression patterns within the spatial data.
  • Pathway Analysis (PROGENY): Assessing the activity of broad signaling pathways across the tissue.
  • Trajectory Gene/Gene Set Modeling (SPATA2): This novel approach models how gene expression changes along a defined path, allowing researchers to visualize and quantify the "penetration" of inflammatory signals from the meninges into the brain.

Datasets

The study utilized spatial transcriptomic data generated from:

  • Four naïve (control) SJL/J mice.
  • Four EAE-induced SJL/J mice.

This data represents a new resource for the field, providing a detailed spatial map of meningeal inflammation and its impact on the adjacent brain parenchyma in a well-established MS model.

Key Insights and Ideas

  • Meningeal Inflammation is a Hotspot: As expected, areas of meningeal inflammation showed a broad upregulation of inflammatory signaling pathways.
  • Selective Penetration, Not Uniform Spread: Crucially, only a subset of these inflammatory pathways found in the meninges were also active in the adjacent brain parenchyma. This suggests a selective rather than a wholesale diffusion of inflammatory signals.
  • Specific Immune Programs "Leak" into the Brain: Sub-clustering of the brain parenchyma adjacent to meningeal inflammation revealed that specific immune programs, notably those related to B cell-mediated immune responses and antigen processing/presentation, were particularly enriched.
  • Gradients of Influence: Trajectory analysis demonstrated that inflammatory gene signatures originating from the meninges showed variable "penetration" into the brain tissue, with some pathways declining more gradually than others. This provides a molecular basis for understanding how meningeal inflammation might differentially affect brain regions.

Key Results

  • The study identified a distinct cluster of upregulated genes in the meninges of EAE mice, enriched for immune cell functions, cytokine production, and interactions.
  • Adjacent brain parenchyma clusters showed enrichment for glial activation, but also adaptive/B-cell mediated immunity and antigen presentation, suggesting these pathways are influenced by meningeal inflammation.
  • Trajectory analysis revealed that pathways like antigen processing and presentation, cell killing, IL-6 production, and IFN-gamma response showed a more gradual decline in activity as they moved away from the meninges into the brain, indicating a sustained influence.

Limitations and Future Work

  • Model Limitations: The EAE mouse model, while useful, is not a perfect replica of MS. It doesn't fully recapitulate cortical subpial demyelination or neuronal loss, which are key features of MS pathology. The authors acknowledge that gene trajectories observed in EAE might not perfectly mirror those in human MS.
  • Resolution of Visium: The Visium technology, while powerful, does not achieve single-cell resolution. This leads to some overlap in gene expression signatures between the meninges and the underlying parenchyma, making it difficult to pinpoint the exact cellular source of all signals.
  • Future Directions: The authors suggest future studies should focus on spatial transcriptomics in post-mortem or biopsied human MS tissue, which would be ideal but faces significant accessibility challenges. They also plan to investigate subpial neuronal loss in their model and generate additional data on microglial activation's role in parenchymal transcriptomic changes. The study also highlights the need for mechanistic studies to further evaluate the role of the identified signaling pathways in driving grey matter pathology.

Summary updated

Abstract

Abstract While modern high efficacy disease modifying therapies have revolutionized the treatment of relapsing-remitting multiple sclerosis, they are less effective at controlling progressive forms of the disease. Meningeal inflammation is a recognized risk factor for cortical grey matter pathology which can result in disabling symptoms such as cognitive impairment and depression, but the mechanisms linking meningeal inflammation and grey matter pathology remain unclear. Here, we performed MRI-guided spatial transcriptomics in a mouse model of autoimmune meningeal inflammation to characterize the transcriptional signature in areas of meningeal inflammation and the underlying brain parenchyma. We found broadly increased activity of inflammatory signaling pathways at sites of meningeal inflammation, but only a subset of these pathways active in the adjacent brain parenchyma. Sub-clustering of regions adjacent to meningeal inflammation revealed the subset of immune programs induced in brain parenchyma, notably the B cell mediated immune response and antigen processing/presentation. Trajectory gene and gene set modeling analysis confirmed variable penetration of immune signatures originating from meningeal inflammation into the adjacent brain tissue. This work contributes a valuable data resource to the field, provides the first detailed spatial transcriptomic characterization in a model of meningeal inflammation, and highlights several candidate pathways in the pathogenesis of grey matter pathology.
BibTeX
@misc{gadani2023spatial,
  author = {Sachin P. Gadani and Saumitra Singh and Sol Kim and Matthew D. Smith and Peter A. Calabresi and Pavan Bhargava},
  title = {{Spatial Transcriptomics of Meningeal Inflammation Reveals Variable Penetrance of Inflammatory Gene Signatures into Adjacent Brain Parenchyma}},
  year = {2023},
  doi = {10.7554/elife.88414.1},
}
Figure